Theravance Biopharma, Inc.·4

Nov 21, 5:43 PM ET

HAUMANN BRETT K 4

4 · Theravance Biopharma, Inc. · Filed Nov 21, 2018

Insider Transaction Report

Form 4
Period: 2018-11-20
HAUMANN BRETT K
SVP, Clinical Development
Transactions
  • Tax Payment

    Ordinary Shares

    2018-11-20$24.79/sh7,368$182,653134,911 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -